Building Biomedical Engineering Education, Research, and Innovation at Historically Black Colleges and Universities (HBCU eBETA) (UG3/UH3 Clinical Trial Not Allowed)
ID: 356720Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity titled "Building Biomedical Engineering Education, Research, and Innovation at Historically Black Colleges and Universities (HBCU eBETA)," aimed at enhancing research capacity and technology innovation in biomedical engineering at HBCUs. This initiative seeks to bolster education and career development in biomedical engineering, with a phased funding approach allowing for up to $300,000 in direct costs for planning (UG3 Phase) and potentially up to $1,000,000 for full-scale program implementation (UH3 Phase). The program emphasizes the importance of diversity in the scientific workforce and aims to address health disparities through improved training and partnerships. Interested applicants must submit their proposals by September 30, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. More details can be found at the provided link: https://grants.nih.gov/grants/guide/rfa-files/RFA-EB-25-002.html.

    Point(s) of Contact
    Files
    Title
    Posted
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is launching the "Building Biomedical Engineering Education, Research, and Innovation at Historically Black Colleges and Universities (HBCU eBETA)" initiative. This funding opportunity aims to bolster research capacity, technology innovation, and education in biomedical engineering at HBCUs. The program adopts a phased approach, allowing institutions to receive up to $300,000 in direct costs for planning (UG3 Phase) and potentially up to $1,000,000 for full-scale program implementation (UH3 Phase). Key components include enhancing academic structures, fostering student career development in biomedical engineering, and establishing partnerships to expand the BEIT workforce. Eligible organizations include higher education institutions specifically HBCUs, and applicants are encouraged to demonstrate institutional commitment and outline detailed milestone plans. The program prioritizes diversity in the scientific workforce, aiming to fill gaps in biomedical innovation and address health disparities. Overall, the initiative reflects NIH's commitment to advancing research capabilities at HBCUs while ensuring comprehensive student training in high-impact fields. The first application submission opens on August 30, 2025, with additional deadlines and guidelines detailed within the announcement.
    Similar Opportunities
    Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering funding through the Exploratory/Developmental Bioengineering Research Grants (EBRG) program, aimed at enhancing biomedical research and clinical care. This initiative encourages innovative applications that focus on developing new capabilities to address challenges in biomedical, preclinical, or clinical settings, with an emphasis on feasibility testing and novel methodologies. The program is particularly significant for advancing cancer research through innovative bioengineering approaches, welcoming proposals from a diverse range of eligible applicants, including universities, nonprofits, and small businesses, especially those representing underrepresented groups. The maximum budget for applicants is $275,000 over two years, with applications due by January 7, 2028. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-25-321.html.
    Enhancing Science, Technology, EnginEering, and Math Educational Diversity (ESTEEMED) Research Education Experiences (R25 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the "Enhancing Science, Technology, Engineering, and Math Educational Diversity (ESTEEMED)" grant to support educational activities aimed at encouraging individuals from diverse backgrounds, particularly those underrepresented in biomedical fields, to pursue research careers. This funding opportunity focuses on enhancing the development of undergraduate students in bioengineering or relevant STEM fields through integrated educational activities, including summer bridge programs, academic year activities, and summer research experiences, with an emphasis on skills development, mentoring, and transitioning students to doctoral studies. The initiative addresses high attrition rates in STEM fields and promotes diversity within the scientific workforce, with funding available for direct costs up to $325,000 per year for a project duration not exceeding four years. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov, with applications due by January 17, 2026.
    Bioengineering Research, Innovation and Technology Education (BRITE) Program (R25 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Bioengineering Research, Innovation and Technology Education (BRITE) Program, a federal grant aimed at fostering the development of undergraduate students in bioengineering and related STEM fields. This program encourages private institutions of higher education to propose integrated educational activities that include a summer bridge program for incoming freshmen, academic year activities, and summer research experiences, ultimately guiding participants toward doctoral degrees or research careers in bioengineering and biomedical imaging. The BRITE Program is crucial for enhancing the capacity for rigorous bioengineering training and addressing the nation's health-related research needs. Interested applicants can contact Dr. Tina Gatlin at gatlincl@nih.gov or by phone at 240-731-3794, with the estimated project start date set for March 1, 2027, and the application window closing on May 11, 2026.
    Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)" aimed at fostering collaborative research partnerships between academic and industrial investigators to accelerate the development of innovative bioengineering tools and technologies. The program seeks to establish multidisciplinary teams that apply a quantitative bioengineering approach to address significant biomedical challenges, with a focus on creating robust solutions that can enhance life science understanding and medical practices within a 5-10 year timeframe. Eligible applicants include a diverse range of organizations such as higher education institutions, nonprofits, and for-profit entities, particularly those emphasizing diversity in research. Interested parties should note that the application deadline is September 7, 2027, and for further inquiries, they can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information page at https://grants.nih.gov/grants/guide/pa-files/PAR-24-325.html.
    Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed), aimed at advancing innovative bioengineering solutions to address cancer and other biomedical challenges. This funding opportunity encourages projects that demonstrate the feasibility and potential utility of novel capabilities to enhance biomedical research, clinical care delivery, and accessibility, while specifically discouraging clinical trial proposals. Eligible applicants include a diverse range of institutions such as higher education entities, nonprofits, for-profit organizations, and foreign entities, with a funding cap of $275,000 available over a two-year period. Interested applicants can find more information and submission guidelines on the NIH website, with applications due by January 7, 2028. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    Research Education Projects
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a federal grant opportunity titled "Research Education Projects" aimed at supporting research education activities within its mission areas. This program, designated as R25, seeks to enhance training opportunities and prepare a skilled workforce to address the nation's biomedical, behavioral, and clinical research needs, while also promoting recruitment into research careers in these fields. The grant is available to small businesses, with no cost-sharing or matching requirements, and is categorized under discretionary funding with a CFDA number of 93.077. Interested applicants can reach out to the Division of Biomedical Research Workforce at NIH via email at NIHTrain@mail.nih.gov or by phone at 301-451-0993 for further information. Key deadlines include an estimated synopsis close date of May 25, 2026, and an estimated award date of February 1, 2027.
    Bridges to the Doctorate Research Training Program (T32)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Bridges to the Doctorate Research Training Program (T32), a federal grant aimed at enhancing participation in the biomedical research workforce by improving training for master's students and facilitating their transition to Ph.D. programs. This program seeks to support eligible domestic organizations in developing effective, evidence-informed approaches to biomedical graduate training and mentoring, with a strong emphasis on outreach to underrepresented groups to promote diversity within the research community. The initiative requires partnerships between at least two postsecondary educational organizations—one focused on master's training and the other on Ph.D. training—while providing comprehensive financial support for trainees, including stipends and travel expenses. Interested applicants must adhere to strict eligibility criteria, with a preference for institutions such as Historically Black Colleges and Universities (HBCUs) and Tribally Controlled Colleges and Universities (TCCUs). The application deadline is September 28, 2026, and further inquiries can be directed to NIH Grants Information at grantsinfo@nih.gov.
    Short-Term Research Education Program to Enhance Diversity in Health-Related Research (R25 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Heart, Lung, and Blood Institute (NHLBI), is offering a federal grant opportunity titled "Short-Term Research Education Program to Enhance Diversity in Health-Related Research (R25 Clinical Trial Not Allowed)." This program aims to support educational activities that enhance the diversity of the biomedical, behavioral, and clinical research workforce by providing research experiences and related opportunities for individuals from underrepresented groups. The initiative is crucial for addressing health disparities in cardiovascular, pulmonary, and hematologic diseases by fostering a diverse scientific workforce. Interested applicants can apply for funding up to $175,000 per year for a maximum of five years, with applications opening on December 29, 2023, and a submission deadline of August 19, 2026. For further inquiries, applicants may contact NIH Grants Information at grantsinfo@nih.gov or visit the program's webpage at https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-25-001.html.
    Notice of Intent to Publish a Funding Opportunity Announcement: Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) aimed at soliciting applications for research focused on developing biomedical technologies that address health disparities. This initiative seeks to support projects that create effective, affordable, and socially acceptable technologies to improve healthcare access and outcomes for underserved populations. The estimated total program funding for this opportunity is $1,200,000, with an expected two awards to be made, and the application process is anticipated to open in late 2025. Interested applicants can reach out to Nichole Daringer at nichole.daringer@nih.gov or call 301-451-4774 for further information.
    NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional) to support innovative research aimed at addressing minority health and health disparities in the United States. This grant invites applications for short-term exploratory projects that can either pioneer new advancements or build upon previous findings, with a maximum funding amount of $275,000 available for a two-year project period, limiting annual requests to $200,000. The program emphasizes the importance of diverse representation among applicants and encourages partnerships with relevant stakeholders, focusing on NIH-designated health disparity populations through various research methodologies. Interested applicants can find more information and submission guidelines at the provided link, with the application deadline set for May 7, 2026. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.